Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By

 


Abstract

To investigate the possible role of poliovirus (PV) infection in the development of Post-Polio Syndrome (PPS), researchers studied serum, cerebrospinal fluid (CSF), peripheral blood lymphocytes, and muscle tissue from 47 PPS patients. Elevated IgM antibodies against poliovirus were identified in a subset of patients, with titers reaching 1:250 compared with less than 1:50 in healthy individuals and disease controls. Using polymerase chain reaction (PCR) techniques targeting the poliovirus replicase gene, PV RNA sequences were detected in peripheral blood lymphocytes from 7 of 37 patients and in the CSF of 4 of 40 patients, while no viral sequences were detected in controls. Sequencing confirmed a 99.3% homology with poliovirus type 1.

These findings suggest that some PPS patients may exhibit an ongoing immune response to poliovirus antigens. The detection of poliovirus RNA raises the possibility of persistent mutated virus or defective viral particles. However, the significance of these observations remains uncertain, and the role of viral persistence in the pathogenesis of PPS has not been conclusively established.

Introduction

Post-Polio Syndrome (PPS) is a neurological condition that affects a proportion of polio survivors decades after apparent recovery from acute poliomyelitis. It is characterized by new muscle weakness, fatigue, pain, reduced endurance, and, in some cases, respiratory or swallowing difficulties. Traditionally, PPS has been viewed as a consequence of chronic motor neuron degeneration resulting from the long-term failure of enlarged motor units formed during recovery from the original infection.

Although the prevailing medical model attributes PPS primarily to progressive motor neuron exhaustion and age-related decline, some studies have suggested that persistent poliovirus infection or residual viral particles may contribute to symptom development in a subset of patients. Evidence supporting this hypothesis includes elevated anti-poliovirus IgM antibody titers and detection of poliovirus RNA in blood lymphocytes and cerebrospinal fluid. These findings remain controversial and have not yet altered the standard clinical understanding of PPS.

Poliovirus Persistence in the Human Body

Following infection, poliovirus rapidly replicates within the throat and gastrointestinal tract.

Incubation Period

  • Poliovirus begins replicating within hours of entering the body.
  • The incubation period typically ranges from 7–10 days but may vary between 3 and 35 days.

Viral Shedding

  • Poliovirus is commonly shed in feces for 4–8 weeks after infection.
  • Individuals may continue shedding virus even after symptoms resolve or when infection is asymptomatic.
  • Rarely, immunocompromised individuals may chronically excrete poliovirus for months or even years.

Bloodstream and Nervous System

  • Viremia generally lasts only a few days before viral clearance or progression into the central nervous system.
  • In a small percentage of infections, poliovirus invades motor neurons within the spinal cord and brainstem, leading to paralysis.

While poliovirus usually persists for only weeks to months, prolonged persistence has been documented in certain immunodeficient individuals.

Historical Challenges in Polio Diagnosis

During the 1950s and early 1960s, many poliovirus infections were misdiagnosed as influenza or nonspecific viral illnesses due to overlapping symptoms and limited laboratory capabilities.

At the time:

  • Routine stool testing for poliovirus was not widely performed.
  • Diagnostic confirmation was often unavailable.
  • Mild and non-paralytic infections frequently went unrecognized.

The introduction of reliable cell culture techniques, including the use of HeLa cell systems, enabled accurate isolation of poliovirus from stool specimens and significantly improved diagnostic accuracy. This development transformed understanding of poliovirus transmission and epidemiology.

Some researchers have suggested that under-recognition of non-paralytic infections may have contributed to an underestimation of the population later at risk for PPS-like symptoms.

Genetic and Epigenetic Considerations

Poliovirus is an RNA virus that does not integrate into the human genome.

Current evidence indicates:

  • Poliovirus does not leave a specific genetic marker within host DNA.
  • No established epigenetic signature has been identified.
  • Long-term consequences are believed to result primarily from irreversible motor neuron injury sustained during acute infection.

Therefore, PPS is generally regarded as a delayed consequence of neuronal damage rather than a genetic or epigenetic disorder.

SV40 Contamination and Historical Vaccine Concerns

Between approximately 1955 and 1963, some polio vaccine batches were inadvertently contaminated with Simian Virus 40 (SV40), a monkey virus present in kidney cell cultures used during vaccine production.

Research has shown:

  • SV40 DNA can be detected in some human tissues.
  • Laboratory studies demonstrate oncogenic potential in experimental models.
  • Human epidemiological studies have not established a definitive causal link between SV40 exposure and PPS.

At present, there is no conclusive evidence implicating SV40 in the development of Post-Polio Syndrome. Nevertheless, the question continues to be discussed in historical and scientific literature.

What Polio Originally Affects

Acute poliomyelitis primarily targets:

  • Anterior horn motor neurons of the spinal cord
  • Motor nuclei within the brainstem (in bulbar polio)

Generally unaffected:

  • Memory
  • Intelligence
  • Personality
  • Higher cognitive functions

Polio is fundamentally a motor neuron disease rather than a disorder of higher brain function.

The Hallmark of Post-Polio Syndrome

The defining feature of PPS is:

New muscular weakness occurring years or decades after recovery from acute poliomyelitis.

Symptoms may involve:

  • Arms
  • Legs
  • Trunk muscles
  • Respiratory muscles
  • Swallowing muscles
  • Speech-related muscles

The condition usually develops after a prolonged period of neurological stability lasting 15–40 years or more.


Below is a concise overview based on the detailed information provided:

Pathophysiology of PPS

Motor Neuron Compensation After Acute Polio

During the original infection:

  • Many motor neurons were permanently destroyed.
  • Surviving neurons compensated through collateral sprouting.
  • New axonal branches reinnervated denervated muscle fibers.
  • Enlarged "giant motor units" were formed, sometimes several times their normal size.

This adaptive process allowed substantial functional recovery.

Progressive Motor Unit Failure

Over subsequent decades:

  • Enlarged motor units become metabolically stressed.
  • Distal axonal sprouts gradually degenerate.
  • Reinnervation capacity declines with aging.
  • Previously recovered muscle fibers become denervated again.

The result is:

  • Progressive muscle weakness
  • Muscle atrophy
  • Reduced endurance
  • Fatigue
  • Pain

This mechanism remains the most widely accepted explanation for PPS.

Neuromuscular Junction Dysfunction

Additional factors may contribute:

  • Reduced acetylcholine synthesis
  • Impaired neurotransmitter release
  • Altered receptor responsiveness

These abnormalities may worsen fatigue and muscle weakness.

Clinical Features

Muscle Weakness

  • Slowly progressive
  • Often asymmetric
  • May affect previously affected and apparently unaffected muscles
  • May be associated with fasciculations

Fatigue

  • Severe exhaustion after minimal activity
  • Delayed recovery following exertion
  • Both generalized and localized muscle fatigability

Pain

  • Muscle overuse pain
  • Joint pain
  • Degenerative musculoskeletal changes

Additional Symptoms

  • Cold intolerance
  • Reduced stamina
  • Respiratory impairment
  • Swallowing difficulties
  • Speech problems

Diagnosis

Diagnosis remains primarily clinical and requires:

Clinical Criteria

  • Documented history of poliomyelitis
  • Long period of neurological stability
  • Gradual onset of new symptoms
  • Exclusion of alternative neuromuscular disorders

Electromyography (EMG)

EMG may demonstrate:

  • Chronic denervation
  • Reinnervation
  • Ongoing motor unit loss

Creatine Kinase (CK/CPK)

Elevated CK levels may reflect:

  • Muscle overuse
  • Ongoing muscle injury
  • Chronic degeneration

Symptoms associated with elevated CK can include:

  • Muscle pain
  • Muscle weakness
  • Cramping
  • Balance difficulties
  • Dark urine
  • Swelling of legs or feet

Differential Diagnosis

Other conditions that may mimic PPS include:

  • Amyotrophic Lateral Sclerosis
  • Myasthenia Gravis
  • Inflammatory myopathies
  • Endocrine disorders
  • Medication-induced myopathy

Is PPS Caused by Active Poliovirus?

Current medical consensus generally holds that PPS is not caused by active poliovirus infection.

However:

  • Elevated anti-poliovirus IgM antibodies have been documented in some patients.
  • Poliovirus RNA has been detected in limited studies.
  • The significance of these findings remains uncertain.

Further research is needed to determine whether viral persistence contributes to PPS in a subset of patients or whether these findings represent residual immune activity without pathogenic significance.

References:

Polio and Post-Polio Syndrome
https://swaresearch.blogspot.com/2023/11/post-polio-syndrome.html

Video: Health Professionals' Guide to Polio and Post Polio Syndrome
https://www.youtube.com/watch?v=CbZJ-pTtzL8

Post-polio syndrome https://www.health.harvard.edu/a_to_z/post-polio-syndrome-a-to-z

Poliomyelitis
https://www.mayoclinic.org/diseases-conditions/polio/symptoms-causes/syc-20376512
and
https://www.mayoclinic.org/diseases-conditions/post-polio-syndrome/diagnosis-treatment/drc-20355674

Post-Polio Syndrome Revisited: https://pmc.ncbi.nlm.nih.gov/articles/PMC10123742/

Describing post-polio syndrome https://pubmed.ncbi.nlm.nih.gov/35672121/

Post-polio syndrome and rehabilitation
https://pubmed.ncbi.nlm.nih.gov/20044320/

Post-polio syndrome and the late effects of poliomyelitis:
Part 2. treatment, management, and prognosis
https://pubmed.ncbi.nlm.nih.gov/29752826/

Characteristics and Management of Postpolio Syndrome
https://jamanetwork.com/journals/jama/article-abstract/192910

Late Effects of Polio https://post-polio.org/education/late-effects-of-polio/

More information https://pubmed.ncbi.nlm.nih.gov/?term=Post+polio

Additional information: https://pubmed.ncbi.nlm.nih.gov/?term=Post+polio

Post-poliomyelitis syndrome- Video abstract [ID 219481]
https://www.youtube.com/watch?v=c0XVX_xPOhE

Post-Polio Syndrome with Marny Eulberg, MD:
https://www.youtube.com/watch?v=hYS9Qu5xakk&t=28s

People with Post-Polio:
Alan Alda: https://www.youtube.com/shorts/KIPbaidkum4

Singer Joni Mitchell Has Crippling Polio
https://jonimitchell.com/library/view.cfm?id=2701

Germany:

Very detailed Video: Poliomyelitis die Spätfolgen und das Post-Polio-Syndrom (PPS)

Der Bundesverband: https://www.polio-selbsthilfe.de/de/Der-Verband/Bundesverband

Read also: Muscle and Nerve Disorders Related to Different Illnesses

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right.
Library of Congress Card Number: LCN 00-192742
ISBN: 0-9703195-0-9

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

Introduction to Adenosine and Tachycardia

By
What is Adenosine? Adenosine is a chemical found in human cells, existing in three forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine is a chemical found in the body that plays many roles, including influencing heart rate and promoting sleep and relaxation. It is also used as a medication to manage certain types of tachycardia, particularly supraventricular tachycardia. Adenosine works by slowing the heart rate through its action on the cardiac tissue. Adenosine production in the body occurs through multiple pathways: Phosphorylation of Adenine: Adenine can be directly phosphorylated to form AMP (adenosine monophosphate), which is then converted to ATP, ADP, and finally adenosine through dephosphorylation reactions. Breakdown of ATP: Adenosine is primarily formed in the body through the breakdown of ATP, which releases energy. ATP can be dephosphorylated stepwise through the action of various enzymes: ATP is first converted to ADP (adeno...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. Acids, whether from external sources (like industrial chemicals) or internal imbalances (such as metabolic disorders), can have profound effects on both the muscular and vascular systems.   Exposure to strong acids or acid imbalances in the body can disrupt cellular function, cause tissue damage, and lead to systemic health problems. This article explores how acids can negatively impact muscular and vascular health, with an emphasis on both external exposure to corrosive acids and internal acid imbalances caused by metabolic disorders or genetic conditions. Since not everyone is affected by ME/CFS or COVID, it could be beneficial to test for genetic predispositions, such as amino acids, particularly fatty acids. 1. External Acid Exposure and Its Effects on Muscular and Vascular Systems 1.1. Muscular Effects Muscle tissue is highly sensitive to changes in pH, and exposure to strong acids ca...
Read more